Bristol-Myers Squibb (BMY)
$42.98
0.31 (0.73%)
BMY Stock Quote Delayed 30 Minutes
3 Defensive Stocks to Shield Your Portfolio in July
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
95.51B
PE Ratio
-13.86
EPS
-3.1
Volume (Avg. Vol.)
17.69M
Day's Range
$41.90 - $43.08
52-Week Range
$39.35 - $65.38
Dividend & Yield
$2.28 (5.30%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
3 Defensive Stocks to Buy During the Market Dip
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside.
You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
Pharmaceutical stocks can be considered risky, but when their trials get approved by FDA, the stock can go to the moon.
7 Dividend Stocks to Buy Now: June 2024
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
3 Warren Buffett Stocks to Buy Now: June 2024
If you have a long-term view of the market, it’s a good time to look for some Warren Buffett stocks to buy now.
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals…
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024.
